De Pandis MF - Search Results

1

Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results.

Stocchi F, Vacca L, De Pandis MF, Barbato L, Valente M, Ruggieri S. Stocchi F, et al. Among authors: de pandis mf. Neurol Sci. 2001 Feb;22(1):93-4. doi: 10.1007/s100720170062. Neurol Sci. 2001. PMID: 11487217 Clinical Trial.

2

[Changes in the nigrostriatal dopamine receptor compartment after continuous dopaminergic infusions in Parkinson disease].

Baronti F, Ruggieri S, Mouradian MM, Bonamartini A, Bocciarelli P, De Pandis MF, Chase TN, Agnoli A. Baronti F, et al. Among authors: de pandis mf. Riv Neurol. 1991 Nov-Dec;61(6):210-4. Riv Neurol. 1991. PMID: 1813972 Italian.

3

Transient atrial fibrillation after subcutaneous apomorphine bolus.

Stocchi F, De Pandis MF, Delfino FA, Anselmo T, Frongillo D. Stocchi F, et al. Among authors: de pandis mf. Mov Disord. 1996 Sep;11(5):584-5. doi: 10.1002/mds.870110520. Mov Disord. 1996. PMID: 8866506 No abstract available.

4

A pharmacological study of cocaine activity in planaria.

Palladini G, Ruggeri S, Stocchi F, De Pandis MF, Venturini G, Margotta V. Palladini G, et al. Among authors: de pandis mf. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996 Sep;115(1):41-5. doi: 10.1016/s0742-8413(96)00053-9. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996. PMID: 8983168

5

Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.

Ruggieri S, De Pandis MF, Bonamartini A, Vacca L, Stocchi F. Ruggieri S, et al. Among authors: de pandis mf. Clin Neuropharmacol. 1997 Jun;20(3):204-9. doi: 10.1097/00002826-199706000-00003. Clin Neuropharmacol. 1997. PMID: 9197942

6

Urinary and anorectal function evaluation in Parkinson's disease.

Stocchi F, Corazziari E, Carbone A, Vacca L, De Pandis MF, Berardelli A, Ruggieri SA. Stocchi F, et al. Among authors: de pandis mf. Adv Neurol. 1999;80:347-51. Adv Neurol. 1999. PMID: 10410740 No abstract available.

7

Modification of respiratory function parameters in patients with severe Parkinson's disease.

De Pandis MF, Starace A, Stefanelli F, Marruzzo P, Meoli I, De Simone G, Prati R, Stocchi F. De Pandis MF, et al. Among authors: de simone g. Neurol Sci. 2002 Sep;23 Suppl 2:S69-70. doi: 10.1007/s100720200074. Neurol Sci. 2002. PMID: 12548348

8

Combination of two different dopamine agonists in the management of Parkinson's disease.

Stocchi F, Berardelli A, Vacca L, Thomas A, De Pandis MF, Modugno N, Valente M, Ruggieri S. Stocchi F, et al. Among authors: de pandis mf. Neurol Sci. 2002 Sep;23 Suppl 2:S115-6. doi: 10.1007/s100720200096. Neurol Sci. 2002. PMID: 12548370 Clinical Trial.

9

Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition.

Stocchi F, Vacca L, Grassini P, De Pandis MF, Battaglia G, Cattaneo C, Fariello RG. Stocchi F, et al. Among authors: de pandis mf. Neurology. 2006 Oct 10;67(7 Suppl 2):S24-9. doi: 10.1212/wnl.67.7_suppl_2.s24. Neurology. 2006. PMID: 17030737 Clinical Trial.

10

Utility of tolcapone in fluctuating Parkinson's disease.

Stocchi F, De Pandis MF. Stocchi F, et al. Among authors: de pandis mf. Clin Interv Aging. 2006;1(4):317-25. doi: 10.2147/ciia.2006.1.4.317. Clin Interv Aging. 2006. PMID: 18046910 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters